Verve Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Verve Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $6.5M | 1.4M | 4.57 |
| 2024-12-31 | $4.2M | 741k | 5.64 |
| 2024-09-30 | $5.1M | 1.0M | 4.84 |
| 2024-06-30 | $6.3M | 1.3M | 4.88 |
| 2024-03-31 | $11M | 831k | 13.28 |
| 2023-12-31 | $6.6M | 474k | 13.94 |
| 2023-09-30 | $2.7M | 206k | 13.26 |
| 2023-06-30 | $5.0M | 267k | 18.75 |
| 2023-03-31 | $3.8M | 263k | 14.42 |
| 2022-12-31 | $7.6M | 394k | 19.35 |
| 2022-06-30 | $1.1M | 75k | 15.29 |
| 2022-03-31 | $2.4M | 106k | 22.82 |
| 2021-12-31 | $1.9M | 52k | 36.88 |
| 2021-09-30 | $2.0M | 42k | 46.99 |